CAS 1260887-85-1

DideMethyl CitalopraM HydrobroMide

Description:

DideMethyl CitalopraM HydrobroMide, identified by its CAS number 1260887-85-1, is a chemical compound related to the class of selective serotonin reuptake inhibitors (SSRIs), which are primarily used in the treatment of depression and anxiety disorders. This substance is a derivative of citalopram, featuring modifications that may influence its pharmacological properties. Typically, SSRIs function by increasing serotonin levels in the brain, thereby improving mood and emotional balance. The hydrobroMide form indicates the presence of hydrobromic acid, which can enhance the solubility and stability of the compound in various formulations. Characteristics such as its molecular weight, solubility, and specific pharmacokinetic properties would be essential for understanding its behavior in biological systems. As with many pharmaceuticals, the safety profile, potential side effects, and interactions with other medications are critical considerations for its use. Further research and clinical studies would provide more detailed insights into its efficacy and safety in therapeutic applications.

Formula: C₁₈H₁₈BrFN₂O

Synonyms:

• DideMethyl CitalopraM HydrobroMide

Didemethyl Citalopram Hydrobromide (>85%)

Controlled Product

CAS: 1260887-85-1

Applications Didemethyl Citalopram Hydrobromide is a metabolite of Citalopram (C505000), an inhibitor of serotonin (5-HT) uptake. Used as an antidepressant.
References Kugelberg, F.C., et al.: J. Anal. Toxicol., 28, 631 (2004); Christensen, A.V., et al.: Eur. J. Pharmacol., 41, 153 (1977); Keller, M.B., et al.: J. Clin. Psychiatry, 61, 896 (2000); Von Moltke, L.L., et al.: Drug Metab. Dispos., 29, 1102 (2001)

Formula: C₁₈H₁₇FN₂O·HBr

Purity: >85%

Color and Shape: Neat

Molecular weight: 377.2

Ref: TR-D439480